|
Applications
of Ionomer glasses |
| Contract
number |
|
BRPR-CT96-0230 |
Proposal
number |
|
BE96-3721 |
| Start
date |
|
01-Jan-97 |
Duration |
|
3 years |
| RTD
programme |
|
Brite-EuRam |
| Coordinator |
|
Dr P V Hatton |
|
Organisation |
|
The University of
Sheffield |
|
Department |
|
Department of Restorative
Dentistry |
| Street |
|
School of Clinical
Dentistry |
| Street |
|
Claremont Crescent |
| Country |
|
UK |
Postcode |
|
S10 2TA |
| Telephone |
|
44 114 2717938/2717930 |
Fax |
|
44 114 2665328 |
| Partner |
|
Associated Dental Products
(GB) |
| Partner |
|
University of Aveiro (P) |
| Partner |
|
DePuy International (GB) |
| Partner |
|
University of Limerick (IR) |
| Additional
Partner |
|
Molecular Sciences Ltd
(GB), Cera-Dynamics Ltd (GB) |
| Summary |
|
The principal aim of this
Basic Research Project is the study of |
|
acid-degradable
fluoro-alumino-phospho-silicate glasses and their |
|
phase separation and
crystallisation behaviour with the objective of |
|
developing new glass and
glass-ceramic materials for application as i) |
|
glass-ceramic inlays based
on apatite for dental use (alternatives to |
|
amalgam), ii) high
strength castable bone substitutes, iii) bioactive |
|
glazes for medical grade
alloys, iv) microporous glasses for industrial |
|
separations of biological
macromolecules, and v) photo-machinable |
|
glass-ceramics for
opto-electronic applications. |
| Achievements
|
|
A range of ionomer glasses have been produced and characterised by |
| (update
April 1999) |
the University of
Limerick. In addition, scale up of glass production has been successfully demonstrated by
two more partners. Six glasses have been selected for further study for each of the
applications described above and processing conditions are currently being optimised.
Tissue culture techniques have confirmed the in vitro biocompatibility of these
materials and this work is ongoing. A wide variety of demonstration pieces have been
produced that show the potential of apatite-mullite glass-ceramics for use as dental
materials and bone substitutes. Key formulations have been protected by patent prior to
further exploitation by partners. |
Previous Next Last
  
|
